S. Korea To Spend Millions Promoting Medical-Robot Development
This article was originally published in PharmAsia News
Executive SummarySouth Korea plans to spend $8 million to promote an industry to develop the technologies behind medical- and security-related robots so the country can become a leader in the sector. The Ministry of Knowledge Economy said 40 percent of the research-and-development funds would go to Curexo to work with Samsung Medical Center to develop a robot specializing in artificial joint surgery. The other 60 percent is for a company specializing in robots providing industrial security. (Click here for more
You may also be interested in...
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.
The coronavirus COVID-19 outbreak poses a “limited immediate risk” to European production and supplies of off-patent drugs, according to industry association Medicines for Europe. However, if the situation continues for an extended period an “important impact” cannot be ruled out.